New biopharma investing models emerge

04/9/2012 | Xconomy

As venture capital contracts, novel investment groups are emerging that include big drugmakers, governments, health care systems and patient advocacy groups, as highlighted in a recent report from Burrill & Co. One example is the Cystic Fibrosis Foundation's partnership with Aurora Biosciences and Vertex Pharmaceuticals, which yielded an innovative drug. But collaborations between for-profit corporations, governments and patient advocates are subject to competing priorities and ethical questions that must be addressed at the outset, writes Luke Timmerman.

View Full Article in:

Xconomy

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC